(Q44349057)

English

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells (English)

1 reference

Europe PubMed Central

2 December 2017

DNA methylation

0 references

1 reference

based on heuristic

inferred from title

author name string

Sepideh Shaker

1

1 reference

Europe PubMed Central

2 December 2017

Mark Bernstein

2

1 reference

Europe PubMed Central

2 December 2017

Louise F Momparler

3

1 reference

Europe PubMed Central

2 December 2017

Richard L Momparler

4

1 reference

Europe PubMed Central

2 December 2017

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

Leukemia Research

1 reference

Europe PubMed Central

2 December 2017

27

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

437-444

1 reference

Europe PubMed Central

2 December 2017

Different Blocks in the Differentiation of Myeloid Leukemic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer epigenetics comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase: a regulator of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone acetylation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance Liquid Chromatographic Analysis of Chemical Stability of 5-aza-2′-Deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900222-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(02)00222-9

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44349057&oldid=2109634157"